Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,606 shares at $460.43 ($1.2M) on 2026-02-11, disclosed to the SEC on 2026-02-12.
Scheduled sale ($1.2M) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $468.41 | 2,140 | $1.0M | 82.4% |
| 2 | $460.43 | 466 | $215K | 17.6% |
| Total | $466.98 avg | 2,606 | $1.2M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-01-09 | $2.1M | — | Filing → |